Literature DB >> 7673154

Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily.

H Sasaki1, K Nagura, M Ishino, H Tobioka, K Kotani, T Sasaki.   

Abstract

A second protein-tyrosine kinase (PTK) of the focal adhesion kinase (FAK) subfamily, cell adhesion kinase beta (CAK beta), was identified by cDNA cloning. The rat CAK beta is a 115.7-kDa PTK that contains N- and C-terminal domains of 418 and 330 amino acid residues besides the central kinase domain. The rat CAK beta has a homology with mouse FAK over their entire lengths except for the extreme N-terminal 88 residues and shares 45% overall sequence identity (60% identical in the catalytic domain), which indicates that CAK beta is a protein structurally related to but different from FAK. The CAK beta gene is less evenly expressed in a variety of rat organs than the FAK gene. Anti-CAK beta antibody immunoprecipitated a 113-kDa protein from rat brain, 3Y1 fibroblasts, and COS-7 cells transfected with CAK beta cDNA. The tyrosine-phosphorylated state of CAK beta was not reduced on trypsinization, nor enhanced in response to plating 3Y1 cells onto fibronectin. CAK beta localized to sites of cell-to-cell contact in COS-7 transfected with CAK beta cDNA, in which FAK was found at the bottom of the cells. Thus, CAK beta is a PTK possibly participating in the signal transduction regulated by cell-to-cell contacts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673154     DOI: 10.1074/jbc.270.36.21206

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

1.  Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF.

Authors:  M Fuortes; M Melchior; H Han; G J Lyon; C Nathan
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

3.  Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.

Authors:  A Takaoka; N Tanaka; Y Mitani; T Miyazaki; H Fujii; M Sato; P Kovarik; T Decker; J Schlessinger; T Taniguchi
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

4.  The role of Ca2+ mobilization and heterotrimeric G protein activation in mediating tyrosine phosphorylation signaling patterns in vascular smooth muscle cells.

Authors:  P P Sayeski; M S Ali; K E Bernstein
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 5.  Oxygen sensing in neuroendocrine cells and other cell types: pheochromocytoma (PC12) cells as an experimental model.

Authors:  Zachary Spicer; David E Millhorn
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration.

Authors:  M Okigaki; C Davis; M Falasca; S Harroch; D P Felsenfeld; M P Sheetz; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

Review 7.  Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction.

Authors:  J A Girault; G Labesse; J P Mornon; I Callebaut
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

Review 8.  Functions of the FAK family kinases in T cells: beyond actin cytoskeletal rearrangement.

Authors:  Nicole M Chapman; Jon C D Houtman
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

9.  PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.

Authors:  L T Duong; P T Lakkakorpi; I Nakamura; M Machwate; R M Nagy; G A Rodan
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 10.  Targeting Pyk2 for therapeutic intervention.

Authors:  Christopher A Lipinski; Joseph C Loftus
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.